Manager, Real-World EvidenceXcenda, AmerisourceBergenCarrollton, Texas, United States
PB0022 - Impact of COVID-19 on thromboembolic events and mortality among patients with non-valvular atrial fibrillation receiving oral anticoagulants
Sunday, June 25, 202318:30 – 19:30 ET